Report cover image

R&D Investment Analysis of the Medtech Sector

Publisher Frost & Sullivan
Published Sep 05, 2024
SKU # MC19153734

Description

R&D Investment Analysis of the Medtech Sector


Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth

Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medtech R&D investments are corporate budgets, venture capital and private equity firms, government grants, public funding, and partnerships and collaborations.

This Frost & Sullivan research on medtech R&D investment covers growth drivers and restraints; analysis of M&A deals, including the top deals in 2022; regional analysis; analysis of external factors impacting medtech R&D investment; predictions for the next decade; and key growth opportunities for companies.

The study focuses on cardiology and neurology as two top therapy areas covering key technological trends involved with significant R&D investments, including recent ones, and major M&A activities.

Investments in cardiology are focused on advanced AI-based diagnostic tools, implant miniaturization, remote patient monitoring, and minimally invasive techniques for surgery.

Investments in neurology are focused on innovation in neuromodulation devices, implants, and wearable monitoring devices.

Key Questions Answered in the Analysis:

What are the key growth drivers and restraints for medtech R&D investment?
What are the key technological trends for medtech R&D investment for cardiology and neurology?
What are the key R&D investment activities in cardiology and neurology?
What are the key M&A activities in cardiology and neurology?
What does the analysis of the top 5 M&A deals in 2022 reveal?
What does the regional analysis for medtech R&D investment reveal?
What external factors impact medtech R&D investments?
What are the predictions for medtech R&D investment during the next decade?
What are the key growth opportunities for market participants?

Table of Contents

    • Why Is It Increasingly Difficult to Grow?
    • The Strategic Imperative 8TM
    • The Impact of the Top 3 Strategic Imperatives on R&D Investment in the Medtech Industry
    • Growth Opportunities Fuel the Growth Pipeline EngineTM
    • Research Methodology
    • Scope of Analysis
    • Medtech R&D Investments and Key Goals
    • Sources of Medtech R&D Investment
    • R&D Spending by Top 4 Medical Devices Companies in 2023
    • Segmentation by Therapy Areas*
    • Growth Drivers
    • Growth Restraints
    • Major Technological Trends in R&D Investments for Medtech: Cardiology
    • Key R&D Investments in Medtech: Cardiology (2024)
    • Key R&D Investments in Medtech: Cardiology (2023)
    • Key M&A Activities in Medtech: Cardiology (2024)
    • Major Technological Trends in R&D Investments for Medtech: Neurology
    • Key R&D Investments in Medtech: Neurology (2024)
    • Key R&D Investments in Medtech: Neurology (2023)
    • Key M&A Activities in Medtech: Neurology
    • Value of M&A Deals in Medical Technology
    • Top 5 M&A Deals of 2022
    • Regional Analysis
    • Impact of External Factors on Medtech R&D Investments
    • Predictions for the Next Decade
    • Growth Opportunity 1: R&D Investment in Developing Countries
    • Growth Opportunity 2: Minimally Invasive Products and AI Integration
    • Growth Opportunity 3: Continuous Patient Monitoring Solutions
    • Technology Readiness Levels (TRL): Explanation
    • Benefits and Impacts of Growth Opportunities
    • Next Steps

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us